Technetium Tc 99m Medronate Injection, Powder, For Solution
Product Images NDC 65174-660

4 FDA label images from Jubilant Draximage Inc., Dba Jubilant Radiopharma · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Technetium Tc 99m Medronate (NDC 65174-660). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Jubilant Draximage Inc., Dba Jubilant Radiopharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of Technetium Tc 99m Medronate showing two phosphonate groups connected by a methylene (CH2) bridge, with hydroxyl and oxygen atoms attached to phosphorus atoms.*
FDA Label Image

Image 1 (Image)

Image 1 (Image)
Label for Technetium Tc 99m Medronate Injection, an intravenous diagnostic agent for skeletal imaging. The label shows dosage details, storage instructions to keep at 25°C (77°F) and use within 12 hours after labeling with oxidant-free Technetium Tc 99m. It includes a radioactive material warning and is labeled by Jubilant DraxImage Inc., Kirkland, Quebec, Canada.*
FDA Label Image

Image 2 (Image 2)

Image 2 (Image 2)
The image shows a flat, unfolded carton packaging for Technetium Tc 99m Medronate Injection powder, labeled as MDP-25. The label indicates a 25 mg strength kit by Jubilant DraxImage Inc., dba Jubilant Radiopharma. It includes dosage and storage instructions, NDC 65174-660.30, and details about the product's intended diagnostic use for skeletal imaging via intravenous administration.*
FDA Label Image

Image 1 (Image1)

Image 1 (Image1)
Label of Technetium Tc 99m Medronate injection powder, branded as DRAXIMAGE MDP-25, for intravenous use. The multidose vial label lists active ingredients including Medronic Acid 25 mg and details storage, preparation, and handling instructions. It is labeled as sterile, non-pyrogenic, Rx only, and manufactured by Jubilant DraxImage Inc., Kirkland, Québec, Canada.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.